That is essential, since the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (the legacy report predictions). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development almost nobody observed. But it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (angel investor). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly before going higher - second wave. I've been covering bitcoin for a long time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. However that's not the big concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so lots of great private business on the brink of striking the general public markets And I have actually been working on a brand-new way for you to invest even before these business go public.
This chance has been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your spot free of charge.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (jeff brown predictions 2021). And when it comes to tech investing, we leave it to the professionals. Luckily, we have several such experts in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we understand (jeff brown predictions for 2021). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing rapid growth and creating amazing chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. tech stock. However despite what many readers may think, this is a pattern that's just starting. Even though the COVID-19 pandemic disrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (future report). Losing 2 months of production and sales truly affects the number of 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More significantly, the delays caused by the pandemic developed a load of pent-up need. Which demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - bleeding edge. Which's not my only 5G forecast When I have actually discussed 5G in the past, I have actually described its three different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services start to be provided (tech stock). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: Many people do not really appreciate the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open a suite of extraordinary applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next important innovation I predict in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just three companies running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is successfully a greenfield chance.
There's room for numerous companies to exist in this space. future report review. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug treatments produced utilizing this innovation. This was one of those developments that nearly nobody discovered. However it's going to have extensive implications for treating illness. And, naturally, there will be plenty of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back possibly substantially prior to going greater. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin - legacy report prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. tech stocks. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, however we might not separately validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like capability to choose winning technology stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding perspective on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his best picks in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated some of the biggest financial occasions of the past twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right whenever, but Jeff Brown's precise predictions have actually earned him legions of dedicated followers. That states a lot about his capability. The Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research offers numerous research services with a wide array of expertises - jeff brown 2021 predictions.
The business is also connected with Bonner & Partners, another well-respected research publisher - jeff brown stock market prediction. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the finest financial investment research has not been available to private investors. It has actually been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown top biotech 2020. The objective of Brownstone Research study is to make that kind of proprietary research readily available to any financiers looking to get an edge in the marketplaces. The objective is easy to deliver special and successful investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of stable success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you know even a little bit about the market, you know that he has a credibility as a King Midas of sorts. exponential tech investor. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In fact, Brown believes S.A.V. jeff brown genetic sequencer stock. might be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding two advanced innovations: artificial intelligence and electrical automobiles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you understand, electric lorries and self-driving cars and truck stocks have actually been big this year, however the Wall Street machine has actually been big on buzz without much tangible result. Despite a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the best possibility of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transport. Basically, this innovation would enable you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You merely get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a hefty chunk of the profits. It sounds crazy, but it might be closed than you think.